63 results
Page 2 of 4
8-K
EX-99.1
uqw6c9eg8
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
8-K
EX-99.2
ocnb1b7 vectkcyr
25 May 23
Regulation FD Disclosure
5:05pm
8-K
EX-99.1
mq2dj8hqajmfx
25 May 23
Regulation FD Disclosure
5:05pm
8-K
rp5ua
25 May 23
Regulation FD Disclosure
5:05pm
8-K
EX-99.1
69t4m4je
9 May 23
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2023 Financial Results
7:45am
8-K
EX-3.1
levf9n3qhh uu1j1
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
S-3
EX-1.2
lq7fjn
9 Nov 22
Shelf registration
4:15pm
8-K
EX-99.2
74f2l8kmfx
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-99.1
liu2c5zvtl hdx
9 Nov 22
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2022 Financial Results
7:45am
8-K
EX-99.1
7yl9i2
9 Aug 22
Results of Operations and Financial Condition
7:36am
8-K
EX-99.1
n352d3j
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
8-K
EX-99.2
34i9043sf
12 May 22
Xilio Therapeutics Reports Pipeline and Business Highlights and First Quarter 2022 Financial Results
7:36am
10-K
bta4d8k
1 Mar 22
Annual report
4:07pm
8-K
EX-99.1
d26lkzzfoh0gfdvkheo
1 Mar 22
Xilio Therapeutics Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial Results
8:00am
8-K
EX-99.1
9gme9b1
6 Jan 22
Xilio Therapeutics Appoints Yuan Xu, Ph.D., to its Board of Directors
7:45am
10-Q
l4ofoix99r zvs47
2 Dec 21
Quarterly report
4:15pm